4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-071193
Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-22 | Exercise or conversion : show line 1 in the form | +10,000 | $7.27 | $72,700 | 31,604 | D |
| 2021-12-22 | Sale : show line 2 in the form | −10,000 | $30.00 | $300,000 | 21,604 | D |
| Open-market sales · 10,000 sh · avg $30.00 · $300,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-22 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −10,000 | 80,000 | D |
Loading xslF345X03/doc4.xml…